Literature DB >> 23815471

In vitro and in vivo characterization of porcine acellular dermal matrix for gingival augmentation procedures.

A M Pabst1, A Happe, A Callaway, T Ziebart, S I Stratul, M Ackermann, M A Konerding, B Willershausen, A Kasaj.   

Abstract

BACKGROUND AND
OBJECTIVE: Recently, porcine acellular dermal matrix (PADM) has been proposed as a possible alternative to autogenous grafts in periodontal plastic surgery. The aim of the present study was to investigate the in vitro responses of four different oral cell lines cultured on a novel PADM. Furthermore, tissue reaction to PADM was evaluated histologically after subcutaneous implantation in mice.
MATERIAL AND METHODS: Human gingival fibroblasts (HGF), human osteoblast-like cells, human umbilical vein endothelial cells and human oral keratinocytes (HOK) were cultured and transferred on to the PADM. A tissue culture polystyrene surface served as the control. The viability of all tested cell lines on PADM was measured by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay and PrestoBlue(®) reagent. The ToxiLight(®) assay was performed to analyze the effect of PADM on adenylate kinase release. PADM was implanted into nude mice subcutaneously and subjected to histological analysis after 21 d.
RESULTS: Using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assays, all tested cell lines cultured on PADM demonstrated a significant increase of viability compared to the control group (each p < 0.001) with the exception of HGF and HOK after 3 d (each p > 0.05). According to the PrestoBlue(®) analysis, all cell lines demonstrated a significant increase of viability compared to the control group at the particular points of measurement after 18 h (HGF p < 0.01; human osteoblast-like cells, human umbilical vein endothelial cells, HOK each p < 0.001). No significant cytotoxic effects of PADM on the tested cell lines could be observed, as assessed by changes in adenylate kinase release. Subcutaneous implantation of PADM into nude mice demonstrated good integration with surrounding tissues and significant revascularization of its collagen structure.
CONCLUSION: Overall, the results suggest that PADM is a promising substitute for autogenous soft tissue grafts in periodontal surgery.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  collagen; collagen matrix; graft; porcine acellular dermis; tissue regeneration

Mesh:

Substances:

Year:  2013        PMID: 23815471     DOI: 10.1111/jre.12115

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  13 in total

1.  Influence of CAD/CAM zirconia for implant-abutment manufacturing on gingival fibroblasts and oral keratinocytes.

Authors:  A M Pabst; C Walter; A Bell; M Weyhrauch; I Schmidtmann; H Scheller; K M Lehmann
Journal:  Clin Oral Investig       Date:  2015-09-23       Impact factor: 3.573

2.  Influence of porcine-derived collagen matrix on endothelial progenitor cells: an in vitro study.

Authors:  Andreas Max Pabst; Karl-Martin Lehmann; Christian Walter; Maximilian Krüger; Stefan-Ioan Stratul; Adrian Kasaj
Journal:  Odontology       Date:  2014-12-09       Impact factor: 2.634

3.  Biofunctionalization of porcine-derived collagen matrix using enamel matrix derivative and platelet-rich fibrin: influence on mature endothelial cell characteristics in vitro.

Authors:  Jung Soo Park; Andreas Max Pabst; Maximilian Ackermann; Maximilian Moergel; Junho Jung; Adrian Kasaj
Journal:  Clin Oral Investig       Date:  2017-07-11       Impact factor: 3.573

4.  Synchrotron-based X-ray tomographic microscopy for visualization of three-dimensional collagen matrices.

Authors:  A M Pabst; W Wagner; A Kasaj; S Gebhardt; M Ackermann; A Astolfo; F Marone; D Haberthür; F Enzmann; Moritz A Konerding
Journal:  Clin Oral Investig       Date:  2014-09-11       Impact factor: 3.573

5.  Volumetric and linear changes at dental implants following grafting with volume-stable three-dimensional collagen matrices or autogenous connective tissue grafts: 6-month data.

Authors:  Nadja Naenni; Stefan P Bienz; Goran I Benic; Ronald E Jung; Christoph H F Hämmerle; Daniel S Thoma
Journal:  Clin Oral Investig       Date:  2017-09-18       Impact factor: 3.573

6.  Root coverage using coronally advanced flap with porcine-derived acellular dermal matrix or subepithelial connective tissue graft: a randomized controlled clinical trial.

Authors:  Kleber Tanaka Suzuki; Cristhiam de Jesus Hernandez Martinez; Milena Irie Suemi; Daniela Bazan Palioto; Michel Reis Messora; Sérgio Luis Scombatti de Souza; Arthur Belem Novaes; Flavia A Chaves Furlaneto; Mario Taba
Journal:  Clin Oral Investig       Date:  2020-05-07       Impact factor: 3.573

7.  Healing of localized gingival recessions treated with a coronally advanced flap alone or combined with an enamel matrix derivative and a porcine acellular dermal matrix: a preclinical study.

Authors:  Y Shirakata; A Sculean; Y Shinohara; K Sena; N Takeuchi; D D Bosshardt; K Noguchi
Journal:  Clin Oral Investig       Date:  2015-11-27       Impact factor: 3.573

8.  Evaluation of Fibrin-Based Interpenetrating Polymer Networks as Potential Biomaterials for Tissue Engineering.

Authors:  Olfat Gsib; Jean-Luc Duval; Mathieu Goczkowski; Marie Deneufchatel; Odile Fichet; Véronique Larreta-Garde; Sidi Ahmed Bencherif; Christophe Egles
Journal:  Nanomaterials (Basel)       Date:  2017-12-10       Impact factor: 5.076

9.  Changes of the peri-implant soft tissue thickness after grafting with a collagen matrix.

Authors:  Gregory-George Zafiropoulos; Giorgio Deli; Oliver Hoffmann; Gordon John
Journal:  J Indian Soc Periodontol       Date:  2016 Jul-Aug

10.  A 3-Year Prospective Study on a Porcine-Derived Acellular Collagen Matrix to Re-Establish Convexity at the Buccal Aspect of Single Implants in the Molar Area: A Volumetric Analysis.

Authors:  Célien Eeckhout; Eline Bouckaert; Dagmar Verleyen; Thomas De Bruyckere; Jan Cosyn
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.